Advertisement

Search Results for "Intellectual Property Law Clinical Trial"

19:30 EDT 19th June 2013 | BioPortfolio

Matching Channels

Interleukin 17 IL 17R IL 17

The IL-17 family consists of six ligands, A-F. IL-17 was originally thought to signal via the classic receptor IL-17R, but IL17 stimulates a receptor complex that consists of the subunits IL-17RA and...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Clinical Approvals - news, views, reports and blogs

Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

Matching News

USPTO: Indian Compulsory License Was Wrong

As tensions continue to mount over intellectual property rights and compulsory licenses issued by some countries for various medicines, the US Patent and Trademark Office has waded into the debate. In...

Report: Intellectual property benefits biotech industry

Stronger intellectual property rights don't hinder the progress of biotechnology research and the growth of the industry, acc -More- 

Intellectual Property Safeguards in China

Diminishing Risk of Copycats - In the Western world, the protection of intellectual property is often a key issue in investing in China. For example, in the book "The Chemical and Pharmaceutical Indus...

One Day Workshop To Be Delivered On Intellectual Property & Contracting, 16 January 2013, Nottingham, UK

Events 4 Healthcare are to deliver a one day workshop focusing on Intellectual Property & Contracting. This workshop will be held at the Nottingham Hilton Hotel on Wednesday 16th January, 2013. The on...

Strong intellectual property protection welcomed by Canadians

More than three-quarters of Canadian citizens agree the country needs better or the same protection of intellectual property (IP) as its major trading partners, say figures from a Nanos Research surve...

Agios, Penn sign intellectual property licensing deal

Agios Pharmaceuticals and The University of Pennsylvania (Penn) have signed a licensing deal concerning new intellectual property useful for developing diagnostic products to identify certain cancer m...

Guest blog: Commercial Value, Capacity and Intellectual Property

Commercial Value, Capacity and Intellectual Property; emerging findings from the UK’s scientific select committee report on regenerative medicine Conference chairman professor Chris Mason welcomed u...

Do intellectual property rights on existing technologies hinder subsequent innovation?

(University of Chicago Press Journals) A recent study published in the Journal of Political Economy suggests that some types of intellectual property rights discourage subsequent scientific research.

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement